A detailed history of Peapod Lane Capital LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Peapod Lane Capital LLC holds 162,769 shares of FLGT stock, worth $3.71 Million. This represents 3.24% of its overall portfolio holdings.

Number of Shares
162,769
Previous 162,227 0.33%
Holding current value
$3.71 Million
Previous $2.74 Billion 18.03%
% of portfolio
3.24%
Previous 3.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025

BUY
$16.86 - $21.81 $9,138 - $11,821
542 Added 0.33%
162,769 $3.24 Billion
Q1 2025

Apr 30, 2025

BUY
$15.28 - $18.95 $806,295 - $999,953
52,768 Added 48.21%
162,227 $2.74 Billion
Q4 2024

Jan 29, 2025

BUY
$16.71 - $22.68 $1.83 Million - $2.48 Million
109,459 New
109,459 $2.02 Billion

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $690M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Peapod Lane Capital LLC Portfolio

Follow Peapod Lane Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapod Lane Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peapod Lane Capital LLC with notifications on news.